StreetInsider.com News Articles

Form 144 ARTIVION, INC. Filed by: Stanton Marshall S.

Thu, 27 Aug 2026 14:36:00 -0400

si-local-file:///var/storage/secattach/20260827/26988957.html

Form 144 ARTIVION, INC. Filed by: Stanton Marshall S.

Thu, 27 Aug 2026 14:36:00 -0400

si-local-file:///var/storage/secattach/20260827/26988957.html

Form 4 ARTIVION, INC. For: Aug 19 Filed by: Mackin James P

Thu, 20 Aug 2026 14:11:00 -0400

si-local-file:///var/storage/secattach/20260820/26955555.html

Form 4 ARTIVION, INC. For: Aug 19 Filed by: Mackin James P

Thu, 20 Aug 2026 14:11:00 -0400

si-local-file:///var/storage/secattach/20260820/26955555.html

Form 144 ARTIVION, INC. Filed by: Mackin James P

Wed, 19 Aug 2026 15:46:00 -0400

si-local-file:///var/storage/secattach/20260819/26949836.html

Form 144 ARTIVION, INC. Filed by: Mackin James P

Wed, 19 Aug 2026 15:46:00 -0400

si-local-file:///var/storage/secattach/20260819/26949836.html

Artivion Inc. (AORT) PT Raised to $40 at Canaccord

Tue, 18 Aug 2026 05:18:17 -0400

Canaccord analyst William Plovanic raised the price target on Artivion Inc. (NYSE: AORT) to $40.00 (from $39.00) while maintaining a Buy rating.

The analyst comments "This note serves as a model update for our Artivion estimates. We are adjusting our revenue estimates to reflect the additional data contained in the company’s 10-Q filing for Q2. Our price target is raised to $40 from $39 due to a change in the comp group multiple, as our 2027 revenue estimate is unchanged. Maintain BUY."

Artivion Inc. (AORT) PT Raised to $40 at Canaccord

Tue, 18 Aug 2026 05:18:17 -0400

Canaccord analyst William Plovanic raised the price target on Artivion Inc. (NYSE: AORT) to $40.00 (from $39.00) while maintaining a Buy rating.

Form 4 ARTIVION, INC. For: Aug 14 Filed by: GREEN ANDREW M

Mon, 17 Aug 2026 15:19:00 -0400

si-local-file:///var/storage/secattach/20260817/26937673.html

Form 4 ARTIVION, INC. For: Aug 14 Filed by: GREEN ANDREW M

Mon, 17 Aug 2026 15:19:00 -0400

si-local-file:///var/storage/secattach/20260817/26937673.html

Form 4 ARTIVION, INC. For: Aug 14 Filed by: Berry Lance A

Mon, 17 Aug 2026 15:18:00 -0400

si-local-file:///var/storage/secattach/20260817/26937668.html

Form 4 ARTIVION, INC. For: Aug 14 Filed by: Berry Lance A

Mon, 17 Aug 2026 15:18:00 -0400

si-local-file:///var/storage/secattach/20260817/26937668.html

Form 144 ARTIVION, INC. Filed by: Berry Lance A

Fri, 14 Aug 2026 15:59:00 -0400

si-local-file:///var/storage/secattach/20260814/26929770.html

Form 144 ARTIVION, INC. Filed by: Berry Lance A

Fri, 14 Aug 2026 15:59:00 -0400

si-local-file:///var/storage/secattach/20260814/26929770.html

Form 144 ARTIVION, INC. Filed by: GREEN ANDREW M

Fri, 14 Aug 2026 15:18:00 -0400

si-local-file:///var/storage/secattach/20260814/26929434.html

Form 144 ARTIVION, INC. Filed by: GREEN ANDREW M

Fri, 14 Aug 2026 15:18:00 -0400

si-local-file:///var/storage/secattach/20260814/26929434.html

Form SCHEDULE 13G/A ARTIVION, INC. Filed by: NOMURA ASSET MANAGEMENT INTERNATIONAL INC.

Fri, 14 Aug 2026 13:54:00 -0400

si-local-file:///var/storage/secattach/20260814/26928636.html

Form SCHEDULE 13G/A ARTIVION, INC. Filed by: NOMURA ASSET MANAGEMENT INTERNATIONAL INC.

Fri, 14 Aug 2026 13:54:00 -0400

si-local-file:///var/storage/secattach/20260814/26928636.html

Form 4 ARTIVION, INC. For: Aug 12 Filed by: Holloway Jean F

Wed, 12 Aug 2026 17:52:00 -0400

si-local-file:///var/storage/secattach/20260812/26914561.html

Form 4 ARTIVION, INC. For: Aug 12 Filed by: Holloway Jean F

Wed, 12 Aug 2026 17:52:00 -0400

si-local-file:///var/storage/secattach/20260812/26914561.html

Form 10-Q ARTIVION, INC. For: Jun 30

Fri, 07 Aug 2026 13:58:00 -0400

si-local-file:///var/storage/secattach/20260807/26890217.html

Form 10-Q ARTIVION, INC. For: Jun 30

Fri, 07 Aug 2026 13:58:00 -0400

si-local-file:///var/storage/secattach/20260807/26890217.html

Artivion Inc. (AORT) PT Raised to $39 at Canaccord

Fri, 07 Aug 2026 06:09:24 -0400

Canaccord analyst William Plovanic raised the price target on Artivion Inc. (NYSE: AORT) to $39.00 (from $36.00) while maintaining a Buy rating.

The analyst comments "Bottom Line: Artivion had an operationally productive quarter that sets the company up to execute its long-term strategy and become the dominate player in Aortic Arch surgery. In the quarter, Artivion closed its acquisition of Endospan, received PMA approval for AMDS, and delivered solid Q2 growth in key areas, On-X and Aortic Stent Grafts. The Endospan acquisition will bring NEXUS to the U.S. with commercialization to begin in earnest in 2027 as inventory is built and

Artivion Inc. (AORT) PT Raised to $39 at Canaccord

Fri, 07 Aug 2026 06:09:24 -0400

Canaccord analyst William Plovanic raised the price target on Artivion Inc. (NYSE: AORT) to $39.00 (from $36.00) while maintaining a Buy rating.

Form 8-K ARTIVION, INC. For: Aug 06

Thu, 06 Aug 2026 16:09:00 -0400

si-local-file:///var/storage/secattach/20260806/26883868.html